Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study

SIMPLE SUMMARY: Over the last 5 years, immune checkpoint inhibitors (ICIs) are increasingly used in the treatment of non-small cell lung cancer (NSCLC) as either monotherapy or in combination with chemo- and/or radiotherapy. However, despite these advances, outcome still remains poor for most patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaes, Rianne D. W., Reynders, Kobe, Sprooten, Jenny, Nevola, Kathleen T., Rouschop, Kasper M. A., Vooijs, Marc, Garg, Abhishek D., Lambrecht, Maarten, Hendriks, Lizza E. L., Rucevic, Marijana, De Ruysscher, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699057/
https://www.ncbi.nlm.nih.gov/pubmed/34944879
http://dx.doi.org/10.3390/cancers13246259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699057/
https://www.ncbi.nlm.nih.gov/pubmed/34944879
http://dx.doi.org/10.3390/cancers13246259

Ejemplares similares